Cogent Biosciences (COGT) Price-to-Earnings (P/E) Ratio
Price: $4.64
Market Cap: $528.29M
Avg Volume: 1.37M
Market Cap: $528.29M
Avg Volume: 1.37M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Price-to-Earnings (P/E) Ratio Summary
Cogent Biosciences's P/E ratios across different time periods:
- TTM: -2.00
- Annual: -2.24
- Quarterly: -3.17
What is P/E Ratio?
The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's stock price to its earnings per share (EPS). It indicates how much investors are willing to pay for each dollar of company earnings.
Related Metrics
- Price-to-Book (P/B) Ratio: 2.23
- Price-to-Sales (P/S) Ratio: 0.00
Annual Ratios
Cogent Biosciences Historical P/E Ratio
Historical P/B Ratio
Historical P/S Ratio
TTM P/E Ratio
-2.00
P/B Ratio (Annual)
2.23
P/S Ratio (Annual)
0.00
Cogent Biosciences Historical Valuation Metrics
The table below shows various valuation metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | P/E Ratio | P/B Ratio | P/S Ratio |
|---|---|---|---|
| 2024 | -2.24 | 2.23 | 0.00 |
| 2023 | -2.43 | 1.82 | 0.00 |
| 2022 | -5.12 | 2.66 | 0.00 |
| 2021 | -4.63 | 1.55 | 0.00 |
| 2020 | -1.87 | 0.53 | 15.81 |
| 2019 | -0.72 | 0.69 | 0.98 |
| 2018 | -3.17 | 1.82 | 11.25 |
| 2017 | -12.89 | 11.61 | 39.32 |
| 2016 | -14.36 | 4.97 | 40.95 |
| 2015 | -39.47 | 3.74 | 87.14 |
Related Metrics
Explore detailed financial metrics and analysis for COGT.